Received Sep 23, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | IM / LA |
hip pain/ muscle and joint pain; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (hip pain/ muscle and joint pain) in a 71-year-old male patient who received mRNA-1283 (MNEXSPIKE PFS) for COVID-19 prophylaxis. No Medical History information was reported. On 12-Sep-2025, the patient received dose of mRNA-1283 (MNEXSPIKE PFS) (Intramuscular use) 1 dosage form. In September 2025, the patient experienced ARTHRALGIA (hip pain/ muscle and joint pain). At the time of the report, ARTHRALGIA (hip pain/ muscle and joint pain) had not resolved. The concomitant medication was not reported by the reporter. It was reported that the patient had hip pain after receiving mNEXSPIKE on 12-Sep-2025. He said he knew that one of the side effects was muscle and joint pain. He felt pain in his hip. Later, he mentioned that he had received the vaccine in his left arm and said the hip pain was also located on the left side. It was unknown if the patient experienced any additional symptoms or events. The treatment medication was not reported by the reporter.